Beyond PTSD: The Promise of Psychedelic Therapy for Moral Injury Recovery

In the evolving landscape of mental health treatment, psychedelic-assisted therapy has emerged as a promising frontier, particularly for conditions that have proven resistant to conventional treatments. While much attention has focused on psychedelics for post-traumatic stress disorder (PTSD), a related but distinct condition—moral injury—may also benefit significantly from these novel therapeutic approaches. For individuals struggling with the profound psychological wounds that arise from experiences that violate their core moral beliefs, psychedelic medicines may offer unique pathways to healing that traditional therapies have been unable to provide.

Understanding Moral Injury: Beyond the Fear Response

Moral injury, though often occurring alongside PTSD, represents a distinct form of psychological trauma. While PTSD is primarily characterized by fear-based responses to life-threatening situations, moral injury stems from experiences that transgress deeply held moral beliefs and expectations. These experiences might involve perpetrating, witnessing, or failing to prevent actions that conflict with one's moral code, or experiencing betrayal by trusted authorities or institutions. "Moral injury is characterized by profound psychological distress arising from morally challenging experiences," explains Dr. Viktoriia Kurkova, lead author of a groundbreaking 2025 scoping review published in Progress in Neuro-Psychopharmacology and Biological Psychiatry. "Unlike PTSD, which is primarily fear-based, moral injury involves complex emotions like shame, guilt, and a fundamental questioning of one's goodness or worth. "This distinction is not merely theoretical—it has significant implications for treatment. Research has shown that moral injury is a strong contributor to treatment-resistant PTSD, with conventional therapies often failing to adequately address the moral dimensions of trauma. According to Kurkova's research, "Moral injury correlates with poor PTSD outcomes, including treatment resistance, isolation, suicidality, and reduced functioning. "The neurobiological underpinnings of moral injury also differ from those of classic PTSD. While traditional PTSD linked to danger-based trauma is associated with heightened activity in the amygdala and related fear circuitry, moral injury involves increased activity in regions such as the precuneus, which is involved in self-referential processing. These neurobiological distinctions suggest that moral injury involves unique pathways that may contribute to its resilience against standard PTSD treatments.

The Central Role of Shame in Moral Injury

At the heart of moral injury lies shame—a powerful, aversive emotion associated with deeply held negative evaluations about oneself. Unlike guilt, which focuses on specific behaviors and typically motivates reparative actions, shame involves global negative judgments about the self ("I am bad" rather than "I did something bad")."Shame induces a submissive disengagement to minimize aggression and ostracization," notes Kurkova. "In this context, self-blame and shame may accentuate avoidance, withdrawal, relational challenges, and dissociation, factors linked to the complexity of post-traumatic illness and poorer outcomes. "This shame component makes moral injury particularly difficult to treat with conventional approaches. Exposure-based therapies that work well for fear-based PTSD may be less effective or even counterproductive for moral injury, as repeatedly revisiting morally injurious events without addressing the underlying moral conflict may reinforce shame rather than resolve it.

The Psychedelic Approach to Moral Healing

Psychedelic-assisted therapy—particularly with substances like MDMA (3,4-methylenedioxymethamphetamine), psilocybin, and LSD (lysergic acid diethylamide)—offers unique mechanisms that may be especially well-suited to addressing the core features of moral injury. "Studies using LSD, psilocybin, and MDMA suggest improved moral injury-related symptoms, such as self-compassion, and reduced shame and guilt," reports Kurkova's team. While no peer-reviewed studies have specifically examined psychedelic-assisted psychotherapy's impact on moral injury, research on related conditions shows promising results that may translate to moral injury treatment.

MDMA: The Empathogen

MDMA, often referred to as a non-classic psychedelic or entactogen, has shown particular promise for trauma-related conditions. The FDA is currently reviewing evidence for MDMA-assisted therapy for PTSD, which may lead to its rescheduling and approval for this purpose. Dr. Leslie Morland and Dr. Joshua Woolley, writing for the VA's National Center for PTSD, explain that MDMA produces effects that include "reduced fear, increased social engagement, increased openness, increased receptiveness to positive affect, increased empathy and compassion, increased feelings of closeness, and increased disclosure of emotional content. "These effects may be particularly valuable for moral injury recovery. MDMA elevates hormones and neurotransmitters that:

• Facilitate the release of oxytocin, which increases levels of empathy and closeness while lowering stress responses
• Increase self-compassion and prosocial feelings, both of which can assist with perspective-taking when recalling a traumatic experience
• Create cognitive flexibility that may support unlearning of distorted beliefs developed through traumatic experiences and the relearning of more helpful beliefs
• Allow people to have higher tolerance when remembering unpleasant memories

Dr. Ron Shore, in a 2023 article in the Journal of Military, Veteran and Family Health, notes that MDMA-assisted therapy "may be particularly valuable for Veterans with moral injury, as it can help individuals process difficult emotions like shame and guilt in a supportive therapeutic context. "The standard protocol for MDMA-assisted therapy, developed by Lykos Therapeutics (formerly MAPS Public Benefit Corporation), includes twelve 90-minute therapy sessions plus three 6-8-hour medicine sessions. This approach has demonstrated significant efficacy for PTSD in phase 3 clinical trials, with large effect sizes compared to placebo with therapy.

Psilocybin: Opening the Mind

Psilocybin, the active compound in certain species of mushrooms, offers another promising avenue for moral injury treatment. Psilocybin acts primarily on serotonin receptors, particularly the 5-HT2A receptor, producing profound alterations in consciousness that can last 4-8 hours. "Psilocybin has been shown to have low physiological toxicity and low abuse potential when orally ingested," note Morland and Woolley. The subjective effects of psilocybin include "changes in perception, cognition, and emotion, including visual and auditory alterations, changes in the perception of time, spiritual experiences, and mystical-type experiences. "Research suggests that psilocybin may help address moral injury through several mechanisms:

• Increasing cognitive flexibility and reducing rigid thinking patterns
• Facilitating meaning-making and spiritual reconnection
• Reducing rumination on negative thoughts
• Promoting neuroplasticity, potentially allowing for restructuring of rigid beliefs about self and others
• Enhancing emotional processing of difficult experiences

A comprehensive 2024 review published in Current Neuropharmacology notes that psilocybin increases "transcription of neuroplasticity-related genes in the prefrontal cortex" and enhances "bottom-up processing," which may help individuals process traumatic memories in new ways.

LSD: Perspective Shifting

LSD, though less studied in contemporary clinical research than MDMA or psilocybin, has also shown potential for addressing symptoms related to moral injury. Early research from the 1950s and 1960s, before LSD was prohibited, suggested efficacy for various psychological conditions, and modern research is beginning to revisit its therapeutic potential. Like psilocybin, LSD acts on serotonin receptors and produces profound alterations in consciousness. Its effects can last 8-12 hours, providing an extended window for therapeutic processing. LSD may help address moral injury by:

• Facilitating profound shifts in perspective
• Reducing defensive mechanisms that maintain negative self-views
• Promoting emotional catharsis and processing
• Enhancing empathy, including self-empathy

Mechanisms of Healing: How Psychedelics May Address Moral Injury

The potential efficacy of psychedelics for moral injury likely stems from several key mechanisms that directly address the core features of this condition.

1. Increased Self-Compassion

Perhaps the most crucial mechanism for moral injury recovery is the enhancement of self-compassion. Psychedelics, particularly MDMA and psilocybin, have been shown to increase self-compassion—the ability to treat oneself with kindness and understanding rather than harsh judgment. "Studies reported rapid, increasing, and sustained self-compassion over time, alongside increases in self-forgiveness and self-acceptance," notes Kurkova's review. This increase in self-compassion directly counters the shame component of moral injury, allowing individuals to view their actions and experiences with greater kindness and understanding.

2. Reduced Shame and Guilt

Closely related to increased self-compassion is the reduction in shame and guilt observed with psychedelic therapy. By temporarily altering default patterns of self-referential thinking, psychedelics may help individuals step outside of entrenched negative self-views and experience themselves from a more compassionate perspective. "The neurobiological distinctions between moral injury and PTSD suggest that interventions targeting self-referential processing, such as psychedelics, may be particularly effective," explains Kurkova. By modulating activity in brain regions involved in self-referential processing, psychedelics may help disrupt the neural patterns that maintain shame and self-condemnation.

3. Enhanced Perspective-Taking

Psychedelics facilitate perspective-taking—the ability to view situations from different angles and consider alternative interpretations. This may be particularly valuable for moral injury, which often involves rigid, absolutist thinking about moral transgressions. "Psychedelics create cognitive flexibility that may support unlearning of distorted beliefs developed through traumatic experiences and the relearning of more helpful beliefs," note Morland and Woolley. This cognitive flexibility may allow individuals to develop more nuanced understandings of morally complex situations, reducing black-and-white thinking that fuels moral condemnation of self or others.

4. Increased Emotional Processing

A key feature of psychedelic experiences is enhanced emotional processing—the ability to access, experience, and work through difficult emotions. For individuals with moral injury, who often avoid or suppress painful emotions related to morally injurious events, this enhanced emotional processing may facilitate healing. "MDMA allows people to have higher tolerance when remembering unpleasant memories," explain Morland and Woolley. "This finding is corroborated in humans following animal studies that showed that MDMA assists with improving fear extinction learning due to reducing amygdala activity, thus allowing for easier recall of traumatic memories for PTSD patients who may otherwise become overwhelmed by emotions."

5. Neuroplasticity and Belief Restructuring

Psychedelics promote neuroplasticity—the brain's ability to form new neural connections and reorganize existing ones. This enhanced neuroplasticity may create a window of opportunity for restructuring rigid beliefs about self and others that maintain moral injury. The 2024 review in Current Neuropharmacology notes that psilocybin increases "transcription of neuroplasticity-related genes in the prefrontal cortex," potentially facilitating the formation of new, more adaptive beliefs and perspectives. This neuroplasticity may be particularly important for moral injury, which often involves deeply entrenched negative beliefs about oneself or the world.

6. Reconnection with Values and Meaning

Moral injury fundamentally involves a disruption of one's moral framework and sense of meaning. Psychedelics, particularly in their ability to occasion mystical-type or spiritually significant experiences, may facilitate reconnection with core values and meaning. "A large proportion of both cohorts rated the experience as among the most personally meaningful and spiritually significant of their lives," notes the Current Neuropharmacology review, referring to participants in studies of psychedelic experiences. This reconnection with meaning and values may be particularly healing for moral injury, which often involves a profound sense of alienation from one's moral foundations.

7. Social Reconnection

Finally, psychedelics—particularly MDMA—enhance feelings of connection and reduce social isolation. This may directly counter the withdrawal and isolation common in moral injury. "MDMA facilitates the release of oxytocin, which increases levels of empathy and closeness while also lowering stress responses," explain Morland and Woolley. This enhanced connection may help individuals rebuild trust and relationships that have been damaged by moral injury, facilitating social reintegration and healing.

Current Research and Future Directions

Despite the promising theoretical foundations for psychedelic treatment of moral injury, direct research on this specific application remains limited. "No peer-reviewed studies examine PAP's impact on MI, revealing a key research gap for trauma-related disorders," notes Kurkova's review. However, several ongoing research initiatives may help fill this gap. The Veterans Health Administration's Office of Research Development is funding research on psychedelic compounds in Veterans, a population with high rates of both PTSD and moral injury. Several studies are exploring whether MDMA-assisted therapy could be further enhanced by augmenting established evidence-based trauma-focused therapies, which may have implications for moral injury treatment. Future research directions might include:

1. Studies specifically examining psychedelic-assisted therapy for moral injury
2. Exploration of different psychedelic compounds for different aspects of moral injury
3. Development of moral injury-specific psychedelic therapy protocols
4. Investigation of long-term outcomes and maintenance of benefits
5. Research on different populations affected by moral injury (military, healthcare workers, first responders)
6. Exploration of cultural and spiritual dimensions of healing moral injury with psychedelics

Considerations and Challenges

While the potential of psychedelic therapy for moral injury is promising, several important considerations and challenges must be addressed.

Safety and Contraindications

Psychedelic therapy is not appropriate for everyone. Individuals with certain psychiatric conditions, such as psychotic disorders or bipolar disorder, may be at increased risk of adverse effects. Careful screening and preparation are essential components of safe psychedelic therapy. Additionally, the current legal status of many psychedelics as Schedule I substances creates significant barriers to access and research. While this is beginning to change, with the FDA reviewing MDMA for PTSD treatment and several jurisdictions decriminalizing certain psychedelics, legal restrictions remain a significant challenge.

Integration and Therapeutic Context

Psychedelic experiences, while potentially transformative, require careful integration to translate insights into lasting change. The therapeutic context in which psychedelics are administered is crucial for their efficacy and safety. "The premise for MDMA-AT is that the therapeutic effects of MDMA are the result of an interaction between the medicine, the psychotherapy component, and the mindset of the participant and the therapists involved," explain Morland and Woolley. This highlights the importance of skilled therapists and appropriate therapeutic frameworks for psychedelic treatment of moral injury.

Cultural and Spiritual Dimensions

Moral injury often involves cultural and spiritual dimensions that must be considered in treatment. Different cultural and religious traditions may have different frameworks for understanding moral transgression, atonement, and forgiveness. Psychedelic therapy may need to be adapted to respect and incorporate these cultural and spiritual dimensions. As Shore notes, "Traditional entheogenic ceremonies have tended to be shamanic, have a purgative element, contain visionary elements, may include encounters with entities or spirits, and are considered to be effective in the treatment of culture-bound illness syndromes that lack a clear underlying cause and do not respond to other treatments."

Conclusion: A New Frontier in Moral Healing

Moral injury represents a significant challenge for conventional mental health treatments, with its unique features of shame, guilt, and moral conflict often proving resistant to standard approaches. Psychedelic-assisted therapy, with its ability to enhance self-compassion, reduce shame, facilitate perspective-taking, and promote emotional processing, offers a promising new frontier in moral healing. While research specifically targeting psychedelic treatment of moral injury remains limited, the existing evidence for related conditions suggests significant potential. As research continues to advance, psychedelic therapy may emerge as a powerful tool for addressing the profound moral wounds that conventional treatments have struggled to heal. For individuals suffering from moral injury—whether Veterans grappling with combat experiences, healthcare workers facing impossible choices during crises, or others confronting the moral complexity of human existence—psychedelic therapy may offer a path from self-condemnation to self-compassion, from isolation to connection, and from moral wounding to moral healing. As we continue to explore this promising frontier, it is essential to proceed with both scientific rigor and ethical sensitivity, recognizing both the potential benefits and the challenges of psychedelic approaches to moral injury. With careful research and thoughtful implementation, psychedelic therapy may help us address one of the most profound and challenging forms of human suffering—the wounds not just to our bodies or minds, but to our moral selves.

References

1. Kurkova, V., Winkler, O., Greenshaw, A., Jetly, R., Swainston, J., Lodewyk, K., Saghari, P., Dennett, E., & Burback, L. (2025). Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review. Progress in Neuro-Psychopharmacology and Biological Psychiatry. https://doi.org/10.1016/j.pnpbp.2025.111333
2. Shore, R. (2023) . Psychedelics for military and Veteran communities? Research, practice, and policy considerations. Journal of Military, Veteran and Family Health, 9(5). https://doi.org/10.3138/jmvfh.9.5.ed01
3. Glatman Zaretsky, T., Jagodnik, K. M., Barsic, R., Hernandez Antonio, J., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C., Danias, G., Lepow, L., & Yehuda, R. (2023) . The Psychedelic Future of Post-Traumatic Stress Disorder Treatment. Current Neuropharmacology, 22(4), 636-735. https://doi.org/10.2174/1570159X22666231027111147
4. Morland, L., & Woolley, J. (2024) . Psychedelic-Assisted Therapy for PTSD. PTSD: National Center for PTSD. https://www.ptsd.va.gov/professional/treat/txessentials/psychedelics_assisted_therapy.asp
5. Griffin, B. J., Purcell, N., Burkman, K., Litz, B. T., Bryan, C. J., Schmitz, M., Villierme, C., Walsh, J., & Maguen, S. (2019) . Moral Injury: An Integrative Review. Journal of Traumatic Stress, 32(3), 350-362.
6. Litz, B. T., Stein, N., Delaney, E., Lebowitz, L., Nash, W. P., Silva, C., & Maguen, S. (2009). Moral injury and moral repair in war veterans: A preliminary model and intervention strategy. Clinical Psychology Review, 29(8), 695-706.
7. Yehuda, R., Daskalakis, N. P., Desarnaud, F., Makotkine, I., Lehrner, A. L., Koch, E., Flory, J. D., Buxbaum, J. D., Meaney, M. J., & Bierer, L. M. (2013). Epigenetic Biomarkers as Predictors and Correlates of Symptom Improvement Following Psychotherapy in Combat Veterans with PTSD. Frontiers in Psychiatry, 4, 118.

The original article can be found here: https://www.sciencedirect.com/science/article/pii/S0278584625000879